CAN.AU · Cann Group Limited

-

Please sign in to comment on CAN.AU

1 Comment

Admin

3 years, 7 months ago

Cann Group Limited is currently in a long term downtrend where the price is trading 19.8% below its 200 day moving average.

From a valuation standpoint, the stock is 68.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 81.3.

Cann Group Limited's total revenue rose by 94.6% to $1M since the same quarter in the previous year.

Its net income has dropped by 12.2% to $-9M since the same quarter in the previous year.

Finally, its free cash flow grew by 82.7% to $-6M since the same quarter in the previous year.

Based on the above factors, Cann Group Limited gets an overall score of 3/5.

ISIN	AU000000CAN2
CurrencyCode	AUD
Exchange	AU
Industry	Drug Manufacturers-Specialty & Generic
Sector	Healthcare

Target Price	5
Beta	1.15
PE Ratio	0.0
Market Cap	60M
Dividend Yield	0.0%

ABOUT

Cann Group Limited

Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

CAN.AU · Cann Group Limited

-

Cann Group Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Cann Group Limited using a moving average strategy